Latest News
MTC With Cushing’s Syndrome Successfully Treated With Selpercatinib
Radiomics Features Differentiate MTC From PTC Nodules
People With Rare Diseases Report Facing Stigma, Poor Quality of Life
Proposed MTC Grading System Combines Proliferative Activity and Necrosis
IMTCGS Grading System Is Reproducible in MTC, Study Says
A Rare Case of Calcitonin-Negative MTC With Metastasis
Tumor Encapsulation: A Possible Biomarker for Better Prognosis in Patients With MTC
Study Identifies Potential New Biomarkers for Thyroid Cancers
Two Case Studies Suggest Pralsetinib Could Cause Delirium in Patients With MTC
Latest Clinical Trials
Features
Rare Disease Day 2022: Health Care Policy and Protections Still Lacking in Many States
NORD and other rare disease organizations around the world will celebrate Rare Disease Day on February 28, 2022, with most events being held virtually.
Thyroid Expert Outlines Best Options for MTC Diagnosis, Surgery
Dr. Haggi Mazeh, chief of surgery at one of Israel’s top hospitals, discusses diagnosing and treating medullary thyroid carcinoma.
Management of Medullary Thyroid Carcinoma Possible, if Caught in Time
MTC “can get aggressive and nasty” but it is not necessarily a death sentence, said surgical oncologist David Goldenberg, MD, FACS, author of a new book.
Patient Perspectives
The Roller Coaster Ride People With MTC Never Get to Leave
One question that will arise for most if not every patient, is the question of prognosis. Whenever I did bring up that question, I never received an answer.
My Medullary Thyroid Carcinoma Journey: Taking an Organ and Giving a Lifelong Chase
Being diagnosed with medullary thyroid carcinoma (MTC) likely means one loses his or her thyroid.
Making the Decision to Start a Family, Despite MTC
As a 25-year-old young adult receiving a cancer diagnosis, starting a family had still been a dream, one that became very uncertain if not obsolete.
MTC Clinical Insights
The Evolution of Our Understanding of Medullary Thyroid Carcinoma
We look at how our understanding of medullary thyroid carcinoma has evolved over the last several decades, and what we now know about treating the cancer.
Understanding the Geographic Differences of RET Mutations in MTC
We take a look at epidemiological data on the global distribution of RET mutations in cases of medullary thyroid carcinoma.
The Far-Reaching Impact of Innovative Clinical Trial Designs in Rare Disease
We examine the lasting impact of innovative clinical trial designs for rare diseases on other clinical experiments.
Case Study: Metastatic MTC Presenting as Cushing’s Syndrome in a 41-Year-Old Man
We discuss the case study of a patient who was diagnosed with medullary thyroid carcinoma with paraneoplastic Cushing‘s syndrome.
Targeting the PDGF/PDGFR Pathway in Cancer Research
We discuss current therapeutic strategies in targeting the PDGF/PDGFR signaling pathway in cancer research.
Rare Care Podcast
Endocrine Surgeon Dr. Haggi Mazeh Describes the Challenges of Treating MTC
- Loading...
Loading...
Loading... 
Loading...